Bellevue Asset Management’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-19	Closed	-$1K	–	494
2024 Q3	$1K	Hold	19	–	–	﹤0.01%	459
2024 Q2	$1.03K	Buy	+19	New	+$1.03K	﹤0.01%	462